Literature DB >> 10066065

Lack of GB virus C/hepatitis G virus sequences in cerebrospinal fluid in patients with central nervous system infections.

M Radkowski, W Przyjalkowski, D Lipowski, L F Wang, T Laskus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10066065     DOI: 10.1080/00365549850161647

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


× No keyword cloud information.
  5 in total

Review 1.  Detection of GB virus C genomic sequence in the cerebrospinal fluid of a HIV-infected patient in China: a case report and literature review.

Authors:  Z Liu; Y Zhang; F Wei; M Xu; D Mou; T Zhang; W Li; D Chen; H Wu
Journal:  Epidemiol Infect       Date:  2015-06-17       Impact factor: 4.434

2.  Deep sequencing for the detection of virus-like sequences in the brains of patients with multiple sclerosis: detection of GBV-C in human brain.

Authors:  John D Kriesel; Maurine R Hobbs; Brandt B Jones; Brett Milash; Rashed M Nagra; Kael F Fischer
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

3.  Infection of Glia by Human Pegivirus Suppresses Peroxisomal and Antiviral Signaling Pathways.

Authors:  M A L Doan; A Roczkowsky; M Smith; G Blevins; F K H van Landeghem; B B Gelman; W G Branton; J T Stapleton; T C Hobman; C Power
Journal:  J Virol       Date:  2021-09-15       Impact factor: 5.103

Review 4.  Human pegivirus detected in a patient with severe encephalitis using a metagenomic pan-virus array.

Authors:  Helena Fridholm; Line Østergaard Sørensen; Maiken W Rosenstierne; Henrik Nielsen; Finn Sellebjerg; Åse Bengård Andersen; Anders Fomsgaard
Journal:  J Clin Virol       Date:  2016-01-29       Impact factor: 3.168

5.  Human Pegivirus in Patients with Encephalitis of Unclear Etiology, Poland.

Authors:  Iwona Bukowska-Ośko; Karol Perlejewski; Agnieszka Pawełczyk; Małgorzata Rydzanicz; Agnieszka Pollak; Marta Popiel; Kamila Caraballo Cortés; Marcin Paciorek; Andrzej Horban; Tomasz Dzieciątkowski; Marek Radkowski; Tomasz Laskus
Journal:  Emerg Infect Dis       Date:  2018-10       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.